David E. Deering

David Deering practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

David Deering's NPI, 1831557966, was assigned on February 3, 2016. David Deering holds Florida license ARNP9261814.

David Deering's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

David Deering's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. David Deering is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Advocate Radiation Oncology. Dmand AI also links David Deering to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Deering practices, 7 sites in all. Vendor and product names are available with a free account.

Family is David Deering's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. David Deering is licensed in Florida.

Dmand AI lists enlarged prostate among the conditions David Deering treats.

CMS data shows 382 Medicare services from David Deering across 5 procedure codes in 2024, for 184 Medicare patients. Medicare paid $20,464 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 184 Medicare patients who saw David Deering in 2024. The largest group is 85 and over, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Deering's median patient age at 71, with 8% women.

In 2024, David Deering wrote 94 Medicare Part D claims for 52 patients. 91% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $1,123 in total drug cost.

David Deering accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Deering as offering telehealth.

CMS Open Payments shows 16 general payments to David Deering from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sumitomo Pharma America, Inc. paid the most, $62.